Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo

Cancer Letters

Volumn 173, Issue 2, 2001, Pages 175-182

  Nishizuka, Itaru ^a   Ichikawa, Yasushi ^a   Ishikawa, Takashi ^a   Kamiyama, Masako ^a   Hasegawa, Satoshi ^a   Momiyama, Nobuyoshi ^a   Miyazaki, Kaoru ^b   Shimada, Hiroshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Angiogenesis; In vivo; Matrilysin; Vascular endothelial cells

Indexed keywords

AGAROSE; ANTISENSE OLIGONUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; DNA; HEMOGLOBIN; MATRILYSIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL LINE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MICROENCAPSULATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; UMBILICAL VEIN;

ANIMALS; CELL DIVISION; CELLS, CULTURED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; CULTURE MEDIA, SERUM-FREE; DNA; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 7; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; SEPHAROSE; UMBILICAL VEINS;

EID: 0035965592     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00634-6     Document Type: Article

References (26)

1. The matrix-degrading metalloproteinases
2. Tumor cell interactions with the extracellular matrix during invasion and metastasis
3. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester
4. Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors
5. Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)
6. Matrilysin is associated with progression of colorectal tumor
7. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis
8. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity
9. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma
10. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors
11. Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model
12. Inhibitory effect of matrilysin antisense phosphorothioate oligonucleotides on human colon cancer cell invasion in vitro
13. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
14. Suppression of matrilysin inhibits colon cancer cell invasion in vitro
15. Evaluation of angiogenic inhibitors with an in vivo quantitative angiogenesis method using agarose microencapsulation and mouse hemoglobin enzyme-linked immunosorbent assay
16. Purification and characterization of extracellular matrix-degrading metalloproteinase, Matrin (PUMP-1), secreted from human rectal carcinoma cell line
17. Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines
18. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
19. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix
20. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact
21. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
22. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site
23. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors
24. Beta-catenin regulates expression of D1 in colon carcinoma cells
25. Identification of c-MYC as a target of the APC pathway
26. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression